Recombinant Human HTR7 Protein, N-His-SUMO

Title: Introduction to Recombinant Human HTR7 Protein

Recombinant Human HTR7 Protein, also known as 5-hydroxytryptamine receptor 7, is a G protein-coupled receptor that is encoded by the HTR7 gene. This protein is found in the central nervous system and plays a crucial role in regulating serotonin signaling. Recombinant Human HTR7 Protein is a synthetic version of this receptor that is produced through genetic engineering techniques. In this article, we will explore the structure, activity, and applications of this important protein.

Structure of Recombinant Human HTR7 Protein

Recombinant Human HTR7 Protein is a transmembrane protein that consists of 445 amino acids. It is composed of seven alpha-helical transmembrane domains, an extracellular N-terminus, and an intracellular C-terminus. The structure of this protein is similar to other G protein-coupled receptors, with the N-terminus being responsible for ligand binding and the C-terminus being involved in signal transduction.

Activity of Recombinant Human HTR7 Protein

Recombinant Human HTR7 Protein is a specific receptor for serotonin, a neurotransmitter that is involved in various physiological processes such as mood regulation, sleep, and appetite. When serotonin binds to the receptor, it causes a conformational change that activates the G protein-coupled signaling pathway. This results in the production of intracellular messengers that ultimately lead to the desired physiological response.

The activity of Recombinant Human HTR7 Protein is not limited to serotonin signaling. Studies have shown that this receptor can also interact with other neurotransmitters and hormones, such as dopamine and melatonin. This suggests that Recombinant Human HTR7 Protein may have a broader role in modulating brain function and behavior.

Applications of Recombinant Human HTR7 Protein

1. Drug development: The serotonin signaling pathway, in which Recombinant Human HTR7 Protein plays a crucial role, has been implicated in various psychiatric disorders such as depression, anxiety, and schizophrenia. Therefore, this protein has been a target for drug development in the treatment of these conditions. Recombinant Human HTR7 Protein can be used in drug screening assays to identify potential compounds that can modulate its activity.

2. Neuroscience research: Recombinant Human HTR7 Protein has been extensively studied in the field of neuroscience to better understand its role in various physiological processes. Researchers use this protein to study the effects of different ligands on its activity and to investigate the signaling pathways involved.

3. Diagnostic tool: Abnormalities in serotonin signaling have been linked to certain neurological disorders. Recombinant Human HTR7 Protein can be used as an antigen in diagnostic tests to detect the presence of autoantibodies against this protein in patients with these disorders.

4. Therapeutic agent: Recombinant Human HTR7 Protein has also been investigated as a potential therapeutic agent. Studies have shown that it can modulate serotonin signaling and have beneficial effects in conditions such as migraine and irritable bowel syndrome.

Conclusion

Recombinant Human HTR7 Protein is a synthetic version of a G protein-coupled receptor that plays a crucial role in serotonin signaling. Its structure consists of seven transmembrane domains and is similar to other G protein-coupled receptors. This protein has various applications in drug development, neuroscience research, diagnostics, and therapeutics. Further studies on Recombinant Human HTR7 Protein may provide valuable insights into its role in the central nervous system and its potential as a therapeutic target for various disorders.